Interview: Rare and orphan diseases and personalized drug development

Unfortunately, more than 700 rare diseases affect more than 30 million people in the US alone and with many of them being life threatening, it is still a concern that most still do not have treatments.

Related Keywords

Peter Benton ,Michael Murphy , ,Worldwide Clinical ,Orphan Drug ,Markets Amp Regulations ,Preclinical Research ,Clinical Development ,Atient Centricity ,Linical Evolution ,Rare Disease ,Orphan Disease ,Research ,Data Management ,Personalized Medicine ,